NCT04312685View on ClinicalTrials.gov

Transitioning to a Valve -Gated Intrathecal Drug Delivery System

NAUnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

April 1, 2023

Study Completion Date

November 30, 2023

Conditions
PainPain, ChronicPain, IntractablePain, Back
Interventions
DEVICE

Prometra II Programmable Pump system - Flowonix Medical

This valve gated Prometra II Programmable Pump system will be replacing prior peristaltic Synchromed II pump

Trial Locations (8)

14626

The Spine Center at Ridgeway, Rochester

37421

Consultants in Pain Management, Chattanooga

40509

Bux Pain Management, Lexington

48034

Michigan Head & Spine Institute, Southfield

66209

Crimson Pain Management, Overland Park

70458

Aust Interventional Pain, Slidell

83404

Pain and Spine Specialists, Idaho Falls

08012

National Spine & Pain Center, Turnersville

Sponsors

Collaborators (1)

Flowonix Medical
All Listed Sponsors
collaborator

Flowonix Medical

INDUSTRY

lead

Bux, Anjum, MD

OTHER

NCT04312685 - Transitioning to a Valve -Gated Intrathecal Drug Delivery System | Biotech Hunter | Biotech Hunter